Actively Recruiting
Effect of Synbiotic as an Adjuvant Therapy in the Treatment of Parkinson's Disease
Led by Tanta University · Updated on 2025-04-10
66
Participants Needed
1
Research Sites
152 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to investigate the possible efficacy and safety of synbiotic preparation of Lactobacillus acidophilus probiotic with prebiotic fibers as an adjuvant therapy in the treatment of Parkinson's disease
CONDITIONS
Official Title
Effect of Synbiotic as an Adjuvant Therapy in the Treatment of Parkinson's Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 45 and 65 years old
- Both sexes
- Patients with Parkinson's disease on dopamine replacement therapy
- Modified Hoehn and Yahr stage, MHY 1-4
You will not qualify if you...
- Use of antibiotics therapy in the preceding month
- Use of other probiotic products in the preceding two weeks
- Scheduled for or history of gastrointestinal tract surgery
- Known allergy to probiotics
- Receiving artificial enteral or intravenous nutrition
- Presence of depression and/or psychosis
- Taking antioxidant and/or anti-inflammatory medications
- Having hyperthyroidism
- Having inflammatory conditions and/or conditions involving oxidative stress
- Smokers
- Modified Hoehn and Yahr stage MHY 5
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Tanta University
Tanta, El Gharbia, Egypt
Actively Recruiting
Research Team
M
Mohamed E Ramadan
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here